When H-2 heterozygous tumor ceJls of the mouse are subjected to immunoselection against the products of one of their H-2 phenotypes, variant cell lines are obtained that lack that H-2 phenotype (reviewed in ref. 1) .
As a means to understanding the relation of leukemia to the Tla locus, which exhibits abnormal expression in TL+ leukemia cells of TL-mouse strains like C57BL/6 (B6), a variadt of this kind was previously selected from a TL + (B6 x A)F1 hybrid leukemia (H-2b/H-2a) by passage in (B6 x A.SW) recipients (H-2b/H-2s) and was found to have lost not only the serological H-2a phenotype but also the TL phenotype determined by the linked (cis) Tlaa allele (2). The serological phenotypes for H-2b, and Tlab were retained. It has now been possible to study this phenotypically negative variant further to determine whether it has undergone genomic loss of the H-2 and Tia regions of the H-2a: Tlaa haplotype.
MATERIALS AND METHODS
Preparation of the Probe. Probe Ila (3) was isolated from the pH-211a clone by digestion with Pst I and Pvu II or with ftha I and Sac I, followed by self-ligation with T4 ligase. The probe was nick-translated to a specific activity of 2 x 108 cpm/,ug with [a-32PJdNTP.
Preparation of DNA. High molecular weight DNA was prepared from normal thymocytes and spleen cells combined or from leukemia cells according to Blin and Stafford (4) , Results similar to those -described above were obtained with BamHI and Bgl II, both of which, like EcoRI, identify RF polymorphisms in both the H.:2:Qa-2;3 and Tla regions.
Biochemical Phenotypes §. Pep-3 (Chromosome 1), Gpi-1 (chromosbme 7), and Es-1 (chromosome 8) are three biochemical markers for which the B6 and A strains differ and which were expressed in the leukemia cells. For all three markers, the dnselected and variant lines displayed the phenotype of hetetozygotes. DNA from host cells contaminating the washed ascites leukemia cells used for these tests can be discounted because such contaminant cells are very scarce and because the intensity of reaction was the same for the unselected and variant cell lines.
Cytogenetics. Q-banded chromosomes were examined from 50 metaphase spreads, each from the unselected and the variant preparations (Fig. 2) Since each of these cells also had 2 normal chromosomes 12, the markers probably were derived through an inter-chromatid exchange between the 2 chromosomes 12 followed by non-disjunction in the progenitor cell. Loss of mar 2, probably again by non-disjunction, resulted in the clone with 41 chromosomes. Thus, the cells with 42 chromosomes are tetrasomic for the entire chromosome 12, whereas those with 41 chromosomes are tetrasomic for the region i21 -* F and disomic for the regions 12cen -* 12B and 12F --ter. Of the 50 variant cells studied, 11 had 42 chromosomes, each with mar 1 and mar 2, whereas the remaining 39 had 41 chromosomes, each with mar 1 alone. The karyotype of these cells, including both chromosomes 17, was otherwise normal. Therefore, the selection applied must have fixed a 42-chromosome cell with mar 1 and mar 2, which also became homozygous at the H-2:Tla region as the progenitor of the variant. The unstable mar 2 was lost in the majority of unselected as well as variant cell populations. DISCUSSION A feature of special interest concerning H-2:Tla loss variants, Which prompted investigation of TL phenotypic losses by H-2-selected variants in the first place (2) , is the possible relation of Tla genes to malignant transformation. The main point is that TL antigens are expressed not only by T-cell leukemias of mice whose thymocytes express TL constitutively (Tlaa; e.g., strain A) but also by T-cell leukemias of TL-null mice whose thymocytes do not express TL (Tlab; e.g., strain B6)-hence, the choice of a (B6 x A)F1 leukemia, which expresses both constitutive (Tlaa) and irregular (Tlab) TL antigens, in determining whether retention of particular Tla alleles is required for the proliferative behavior of TL+ leukemias. We now see that this is not so for the constitutive Tlaa allele of the leukemia in question.
Whatever genomic abnormality there may be in the Tlab locus retained by the variant, which exhibits abnormal expression in leukemia cells, it was not revealed in the present study since the RF banding pattern of the unselected leukemia cells did not demonstrably differ from that of normal (B6 x A)F1 cells nor did the RF patterns of the variant cells and of TL+ and TL-B6 leukemia cells demonstrably differ from that of normal B6 cells.
A reciprocal (H-2b:Tlab negative) variaht was previously selected from the same leukemia by passage in (A x B6-H2k)F1 recipients (H-2a/H-2k) and its proliferative capacity also was not changed (9) . Unfortunately, this variant did not survive frozen storage, and it is unsafe to assume that it also arose by genomic loss of an H-2:Tla haplotype. Immunoselection for loss of both H-2 haplotypes has never succeeded with tumors of any kind [loss due to a ,2M mutation is another matter since this does not involve genomic loss of H-2 (10, 11)] and the question remains whether a change at both Tia loci may be obligatory in leukemic cellular proliferatioh.
With regard to mechanisms of variant formatiof, there is no reason to suppose that they are peculiar to transformed cells, though much more difficult to study in normal somatic cells. Somatic segregation and mitotic recombination were originally favored in the case of H-2 loss variants because it was often possible to select partial loss variants of H-2K :H-2D+ type with respect to one haplotype but rarely or never the H-2K+:Il-2D-type ("polarity") (1) . This mechanism seemed to be ruled out when it was later found that the centromerb of chromosome 17 lies on the K rather than the D side of H-2, but Susumu Ohno (personal communication) points out that somatic recombination accompanied by reduction and subsequent duplication of chromosome 17 would give the K-D polarity actually observed.
More generally, likely cyto'enetic mechanisms that can account for the formation of variants of the sort in question are the following: (i) hemizygosity, attained either by deletion of a chromosome segment or by chromosome loss from non-disjunction, and (ii) homozygosity, attained by point mutation, chromosome loss by non-disjunction followed by duplication of thd remaining chromosome by a second non-disjunction, or mitotic recombination. Monosomy is relatively common in human leukemia cells (12) ; indeed, in a subset of acute lymphoblastic leukemia the entire autosomal complement may become monosomic, giving rise to near-haploid genomes (13, 14) . Cytological evi- (21) (22) (23) (24) .
In the present study, analysis of both restriction enzyme fragments and chromosomes indicated that loss of the H2a:Tlaa haplotype by the variant was accompanied by duplication of the H-2b: Tiab haplotype. Rajan et al. (25) recently isolated H-2" and H-2d loss variants from an H-2b/ H-2d heterozygous Friend leukemia cell line L3y immunoselection with antisera against the respective haplotypes. Their studies of restriction enzyme fragments and alleles at the H-2-linked locus Glyoxylase-I (Glo-i) also implied attainment of homozygosity for the remainlhg H-2 type following selection. Those results and ours are consistent with an origin of homozygosity by mitotic recombination, although formally neither set of data permits distinction between non-disjunctional loss of a chromosome followed by duplication of its homologue and mitotic recombination. Certainly the length of chromosome rendered homozygous can extend from unselected loci on the centromeric side of H-2 (Glo-i) to unselected loci on the telomeric side (Tia).
Thus, loci to which no selection pressure has been applied may be rendered homozygous if they are linked to the immunoselected H-2 complex.
Events at other heterozygous loci that are not H-2 linked are of interest because they bear on the question of whether the variant-producing mechanism affected only chromosome some pair-in this case, chromosome 17-particularly since Gpi-J is probably <15 centimorgans from its centromere.
The marker chromosomes observed are of interest in another context. The distal breakpoint in mar 1 is in band 12F2 at which chromosome 12 also rearranges in one of the two consistent translocations reported in Pristine-induced plasinacytomas in BALB/c mice-namely, t(12;15)(F2;D3) (26) . In this translocation, the cellular oncogene myc, normally located on chromosome 15 , is translocated into the immunoglobulin heavy chain (IgH) locus, whose position previously has been determined to be distal to band 12F1 (27) . The rearranged c-myc has been shown to undergo activation (28) . A parallel translocation of human c-myc, normally located at 8q24 (29) to the IgH locus, at 14q32 (30) has also been shown to lead to c-myc activation in Burkitt lymphoma (31, 32) . In the human autosomal recessive disorder ataxia-telangiectasia (A-T), a primary immunodeficiency that strongly predisposes to lymphoid neoplasia, a translocation occurring in the T lymphocytes of a number of patients involves the 2 chromosomes 14 with breaks in a proximal (q12) and a distal band (14q23) (33) ; the latter, as noted above, is in the region IgH. A-T lymphocytes with the 14-14 translocation exhibit proliferative advantage and eventually become the only recognizable T cells in the peripheral circulation (34) . Possibly the rearrangement causes activation of a T-cell proliferationrelated gene normally situated at 14q12. As with the 14-14 translocation in A-T, the 12-12 translocation observed in the H-2a loss variant also may transpose a proximal gene into the distal IgH locus on chromosome 12 . The significance of this rearrangement in the evolution of the class of leukemias represented in the present study remains to be determined.
